methane has been researched along with Parkinson Disease in 15 studies
Methane: The simplest saturated hydrocarbon. It is a colorless, flammable gas, slightly soluble in water. It is one of the chief constituents of natural gas and is formed in the decomposition of organic matter. (Grant & Hackh's Chemical Dictionary, 5th ed)
methane : A one-carbon compound in which the carbon is attached by single bonds to four hydrogen atoms. It is a colourless, odourless, non-toxic but flammable gas (b.p. -161degreeC).
Parkinson Disease: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)
| Excerpt | Relevance | Reference |
|---|---|---|
| " Therefore, it is critical to control the levodopa dosage accuracy to improve the curative effect in clinical." | 1.51 | Smartphone-based differential pulse amperometry system for real-time monitoring of levodopa with carbon nanotubes and gold nanoparticles modified screen-printing electrodes. ( Cheng, C; Ji, D; Liu, J; Liu, Q; Liu, Z; Low, SS; Shi, Z; Xu, H; Xu, N; Yu, X; Zhang, T; Zhu, J, 2019) |
| "Benserazide is an irreversible inhibitor of peripheral aromatic L-amino acid decarboxylase that prevents the breakdown of levodopa in the bloodstream." | 1.48 | Nanocarrier for levodopa Parkinson therapeutic drug; comprehensive benserazide analysis. ( Etminan, N; Rahmanifar, E; Yoosefian, M, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (33.33) | 24.3611 |
| 2020's | 9 (60.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dănău, A | 1 |
| Dumitrescu, L | 1 |
| Lefter, A | 1 |
| Tulbă, D | 1 |
| Popescu, BO | 1 |
| TANAKA, GM | 1 |
| EDWARDS, JC | 1 |
| Alimohammadi, E | 2 |
| Nikzad, A | 2 |
| Khedri, M | 2 |
| Shafiee, S | 1 |
| Miri Jahromi, A | 1 |
| Maleki, R | 2 |
| Rezaei, N | 2 |
| Dong, H | 1 |
| Zhao, L | 1 |
| Zhu, X | 1 |
| Wei, X | 1 |
| Zhu, M | 1 |
| Ji, Q | 1 |
| Luo, X | 1 |
| Zhang, Y | 1 |
| Zhou, Y | 1 |
| Xu, M | 1 |
| Carneiro, P | 1 |
| Loureiro, JA | 1 |
| Delerue-Matos, C | 1 |
| Morais, S | 1 |
| Pereira, MDC | 1 |
| Zhang, R | 1 |
| Wang, S | 1 |
| Huang, X | 1 |
| Yang, Y | 1 |
| Fan, H | 1 |
| Yang, F | 1 |
| Li, J | 1 |
| Dong, X | 1 |
| Feng, S | 1 |
| Anbu, P | 1 |
| Gopinath, SCB | 1 |
| Xin, T | 1 |
| Kim, OH | 1 |
| Park, JH | 1 |
| Son, JI | 1 |
| Kim, KY | 1 |
| Lee, HJ | 1 |
| Sonuç Karaboğa, MN | 1 |
| Sezgintürk, MK | 1 |
| Rezaian, M | 1 |
| Jahromi, AM | 1 |
| Mobed, A | 1 |
| Razavi, S | 1 |
| Ahmadalipour, A | 1 |
| Shakouri, SK | 1 |
| Koohkan, G | 1 |
| Costa, C | 1 |
| Miozzi, E | 1 |
| Teodoro, M | 1 |
| Briguglio, G | 1 |
| Rapisarda, V | 1 |
| Fenga, C | 1 |
| Yoosefian, M | 1 |
| Rahmanifar, E | 1 |
| Etminan, N | 1 |
| Ji, D | 1 |
| Xu, N | 1 |
| Liu, Z | 1 |
| Shi, Z | 1 |
| Low, SS | 1 |
| Liu, J | 1 |
| Cheng, C | 1 |
| Zhu, J | 1 |
| Zhang, T | 1 |
| Xu, H | 1 |
| Yu, X | 1 |
| Liu, Q | 1 |
| Sun, CL | 1 |
| Su, CH | 1 |
| Wu, JJ | 1 |
| Qi, L | 1 |
| Thomas, E | 1 |
| White, SH | 1 |
| Smith, SK | 1 |
| Lee, CA | 1 |
| Wilson, LR | 1 |
| Sombers, LA | 1 |
3 reviews available for methane and Parkinson Disease
| Article | Year |
|---|---|
Small Intestinal Bacterial Overgrowth as Potential Therapeutic Target in Parkinson's Disease.
Topics: Blind Loop Syndrome; Dysbiosis; Gastrointestinal Microbiome; Humans; Hydrogen; Intestine, Small; Met | 2021 |
Biosensors in Parkinson's disease.
Topics: Aged; alpha-Synuclein; Biosensing Techniques; Gold; Humans; Metal Nanoparticles; Nanotubes, Carbon; | 2021 |
New insights on 'old' toxicants in occupational toxicology (Review).
Topics: Asbestos; Benzene; Environmental Pollutants; Humans; Nanotubes, Carbon; Neoplasms; Occupational Dise | 2017 |
12 other studies available for methane and Parkinson Disease
| Article | Year |
|---|---|
Treatment of Parkinson's syndrome with tropine benzohydryl ether methane sulfonate and other drugs.
Topics: Ether; Mesylates; Methane; Muscle Relaxants, Central; Parkinson Disease; Propionates; Tropanes | 1952 |
Molecular Tuning of the Nano-Bio Interface: Alpha-Synuclein's Surface Targeting with Doped Carbon Nanostructures.
Topics: alpha-Synuclein; Graphite; Humans; Nanotubes, Carbon; Parkinson Disease; Silicon | 2021 |
Development of a novel ratiometric electrochemical sensor for monitoring β-galactosidase in Parkinson's disease model mice.
Topics: Animals; beta-Galactosidase; Biosensing Techniques; Carbon Fiber; Electrochemical Techniques; Limit | 2022 |
Nanostructured label-free electrochemical immunosensor for detection of a Parkinson's disease biomarker.
Topics: alpha-Synuclein; Biomarkers; Biosensing Techniques; Electrochemical Techniques; Electrodes; Gold; Hu | 2023 |
Gold-nanourchin seeded single-walled carbon nanotube on voltammetry sensor for diagnosing neurogenerative Parkinson's disease.
Topics: alpha-Synuclein; Antibodies, Immobilized; Biomarkers; Electrochemical Techniques; Electrodes; Gold; | 2020 |
Both Intracranial and Intravenous Administration of Functionalized Carbon Nanotubes Protect Dopaminergic Neuronal Death from 6-Hydroxydopamine.
Topics: Administration, Intravenous; Animals; Antioxidants; Behavior, Animal; Cell Death; Cell Differentiati | 2020 |
A nano-composite based regenerative neuro biosensor sensitive to Parkinsonism-associated protein DJ-1/Park7 in cerebrospinal fluid and saliva.
Topics: Biosensing Techniques; Electrochemistry; Gold; Humans; Metal Nanoparticles; Nanocomposites; Nanotube | 2021 |
Potential treatment of Parkinson's disease using new-generation carbon nanotubes: a biomolecular
Topics: alpha-Synuclein; Amyloid; Humans; Molecular Dynamics Simulation; Nanotubes, Carbon; Parkinson Diseas | 2021 |
Nanocarrier for levodopa Parkinson therapeutic drug; comprehensive benserazide analysis.
Topics: Adsorption; Benserazide; Electrons; Hydrogen Bonding; Levodopa; Models, Molecular; Molecular Conform | 2018 |
Smartphone-based differential pulse amperometry system for real-time monitoring of levodopa with carbon nanotubes and gold nanoparticles modified screen-printing electrodes.
Topics: Antiparkinson Agents; Biosensing Techniques; Drug Monitoring; Electrochemical Techniques; Electrodes | 2019 |
Synthesis of short graphene oxide nanoribbons for improved biomarker detection of Parkinson's disease.
Topics: Ascorbic Acid; Biomarkers; Biosensing Techniques; Dopamine; Graphite; Humans; Nanotubes, Carbon; Oxi | 2015 |
Unmasking the Effects of L-DOPA on Rapid Dopamine Signaling with an Improved Approach for Nafion Coating Carbon-Fiber Microelectrodes.
Topics: Animals; Brain; Carbon; Carbon Fiber; Dopamine; Electrochemical Techniques; Electrodes, Implanted; E | 2016 |